Nancy E. Davidson
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.01%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
- Cancer Research 135
- Breast Cancer Treatment Studies 109
- Oncology 154
- HER2/EGFR in Cancer Research 56
- Cancer Treatment and Pharmacology 34
- Co-authors
- Edith A. Perez (34 shared papers)James D. Yager (3 shared papers)Silvana Martino (32 shared papers)Yvonne Lynn Ottaviano (6 shared papers)Stephen B. Baylin (9 shared papers)Julie R. Gralow (16 shared papers)Molin Wang (6 shared papers)Jean‐Pierre J. Issa (5 shared papers)
- Journals
- Journal of Clinical Oncology (67 papers)Breast Cancer Research and Treatment (23 papers)Clinical Cancer Research (19 papers)JNCI Journal of the National Cancer Institute (15 papers)New England Journal of Medicine (12 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Nancy E. Davidson
422 papers receiving 60.3k citations
Nancy E. Davidson's Hit Papers
Peers
Comparison fields: 5 of 190
- Cancer Research 18.2k
- Oncology 25.4k
- Genetics 9.0k
- Molecular Biology 19.8k
- Pulmonary and Respiratory Medicine 7.3k
Countries citing papers authored by Nancy E. Davidson
This map shows the geographic impact of Nancy E. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Davidson more than expected).
Fields of papers citing papers by Nancy E. Davidson
This network shows the impact of papers produced by Nancy E. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Davidson. The network helps show where Nancy E. Davidson may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy E. Davidson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 430 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Hit paper breakdown → | 2005 | 4380 |
| 2 | Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Hit paper breakdown → | 2013 | 2950 |
| 3 | Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer Hit paper breakdown → | 2007 | 2579 |
| 4 | Mutations in the p53 gene occur in diverse human tumour types Hit paper breakdown → | 1989 | 2456 |
| 5 | Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Hit paper breakdown → | 1993 | 1731 |
| 6 | Estrogen Carcinogenesis in Breast Cancer Hit paper breakdown → | 2006 | 1520 |
| 7 | A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer Hit paper breakdown → | 2003 | 1473 |
| 8 | AACR Project GENIE: Powering Precision Medicine through an International Consortium Hit paper breakdown → | 2017 | 1437 |
| 9 | Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 Hit paper breakdown → | 2003 | 1283 |
| 10 | Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Hit paper breakdown → | 1995 | 1196 |
| 11 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Hit paper breakdown → | 2009 | 1150 |
| 12 | Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 Hit paper breakdown → | 2014 | 1069 |
| 13 | Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Hit paper breakdown → | 1994 | 1049 |
| 14 | Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Hit paper breakdown → | 2005 | 908 |
| 15 | Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials Hit paper breakdown → | 2017 | 844 |
| 16 | 2008 | 779 | |
| 17 | American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options Hit paper breakdown → | 2015 | 775 |
| 18 | Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 Hit paper breakdown → | 2014 | 774 |
| 19 | E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Hit paper breakdown → | 1995 | 696 |
| 20 | American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer Hit paper breakdown → | 2010 | 661 |
About Nancy E. Davidson
Nancy E. Davidson is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 430 papers that have together received 62.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (109 papers), Estrogen and related hormone effects (75 papers), Epigenetics and DNA Methylation (57 papers), HER2/EGFR in Cancer Research (56 papers), Cancer Treatment and Pharmacology (34 papers), Histone Deacetylase Inhibitors Research (29 papers), Advanced Breast Cancer Therapies (24 papers) and Cancer-related gene regulation (24 papers). The work is most often cited by research in Cancer Research (18.2k citations), Oncology (25.4k citations), Genetics (9.0k citations), Molecular Biology (19.8k citations) and Pulmonary and Respiratory Medicine (7.3k citations). Nancy E. Davidson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Edith A. Perez, James D. Yager, Silvana Martino, Yvonne Lynn Ottaviano, Stephen B. Baylin, Julie R. Gralow, Molin Wang, Jean‐Pierre J. Issa, George W. Sledge and Scott H. Kaufmann. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research, JNCI Journal of the National Cancer Institute and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.